Cardinal Health Projects 13-15% EPS Growth Driven by Specialty Services
US-based healthcare services and products company, Cardinal Health, is targeting a 13% to 15% growth in its earnings per share (EPS). This projected increase is primarily attributed to strong momentum in its specialty solutions business.
Key takeaways
- US healthcare firm Cardinal Health targets 13-15% earnings per share (EPS) growth.
- This growth is attributed to strong performance in its specialty solutions business.
- The projection signals positive momentum in a key segment for the global healthcare giant.
Cardinal Health, a prominent US-based healthcare services and products company, has announced a projected earnings per share (EPS) growth target of 13% to 15%. This optimistic outlook is reportedly driven by robust performance and increasing momentum within its specialty solutions business segment.
The company, which plays a significant role in the healthcare supply chain, anticipates this growth as its specialty offerings continue to expand and gain traction. This projection reflects the company's confidence in its strategic focus on high-growth areas within the global healthcare sector, indicating positive internal business drivers.
This report is for informational purposes only and not investment advice.
Frequently asked questions
What is Cardinal Health's projected EPS growth?
Cardinal Health is targeting an earnings per share (EPS) growth of 13% to 15%.
What is driving this growth for Cardinal Health?
The projected growth is driven by increasing momentum in the company's specialty solutions business.
What kind of company is Cardinal Health?
Cardinal Health is a US-based company involved in healthcare services and products.